Patent Yard Sign in
Canadian application, no grantCanada

Poly(potassium and sodium styrene sulfonate), its manufacture and its uses

CA 2492211 A1 · Owner: Katti, Sanjeev S. · Inventors: Katti, Sanjeev S.; Bhagat, Hitesh R.; Chancellor-Adams, Toni G.

CIPO record

Overview

Drawings and full text

Its claims, description and drawings are in the Canadian Patents Database.

Open the CIPO record

Abstract From the Canadian patent

Antibiotic-associated diarrhea, such as that caused by Clostridium difficile represents a serious medical complication that can result from administering a broad~spectrum antibiotic to a subject. Such diarrhea leads to significant potassium loss from the subject. The present invention discloses a polymeric therapeutic agent that treats antibiotic-associated diarrhea and is physiologically potassium neutral. This polymer contains polystyrene sodium sulfonate and polystyrene potassium sulfonate repeat units.

Read the whole patent

Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Filed July 18, 2003. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended July 18, 2023.
  • A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by July 18, 2025.
  • We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledJuly 18, 2003
GrantedNo grant recorded
Term endedJuly 18, 2023
Patent numberCA 2492211 A1
Classification (IPC)C08F212/14 +2 more

Timeline

Timeline From CIPO dates

2004200620082010201220142016201820202022Application filedJuly 18, 2003Term endedJuly 18, 2023

Sources & verification

Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.